Integrin Antagonists

Integrin Antagonist is a pharmacological agent that selectively inhibits integrin receptors, a class of cell adhesion molecules, by blocking their interaction with ligands to modulate inflammatory cell trafficking and activation in the context of inflammatory disease therapeutics.

807

Publications

60.1K

Citations

5K

Authors

1.1K

Institutions

Publications per year

2017–2026

131

Variants

Integrin Antagonist

Authors

5K

  1. HK
    Horst Kessler

    Technical University of Munich, Germany

    26 publications · 4.1K citations

    23

    h-index

  2. SA
    Shaker A. Mousa

    Albany College of Pharmacy and Health Sciences, United States

    27 publications · 1.5K citations

    20

    h-index

  3. SL
    Simon L. Goodman

    Merck KGaA, Darmstadt (Germany), Germany

    22 publications · 3.8K citations

    20

    h-index

  4. DA
    David A. Cheresh

    Scripps Research Institute, United States

    15 publications · 7.1K citations

    15

    h-index

  5. CM
    Cezary Marcinkiewicz

    Temple University, United States

    16 publications · 932 citations

    14

    h-index

1–5 of 5K

Venues

  1. Journal of Medicinal Chemistry

    42 publications · 3.6K citations

    31

    h-index

  2. PubMed

    Repository · 40 publications · 4.2K citations

    29

    h-index

  3. Journal of Biological Chemistry

    JBC · 29 publications · 2.8K citations

    26

    h-index

  4. Bioorganic & Medicinal Chemistry Letters

    31 publications · 720 citations

    17

    h-index

  5. Journal of Clinical Investigation

    JCI · 15 publications · 3.3K citations

    14

    h-index

1–5